<DOC>
	<DOC>NCT01366625</DOC>
	<brief_summary>The purpose of this study is to investigate the clinical utility of renal denervation for the treatment of resistant hypertension coexisting with obstructive sleep apnea.</brief_summary>
	<brief_title>Renal Denervation in Patients With Resistant Hypertension and Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>&gt;= 18 and =&lt; 70 years of age. systolic blood pressure &gt;=140mmHg (office); on 3 or more antihypertensive medications (including diuretic) mean daytime systolic ABPM &gt;= 135 mmHg obstructive sleep apnea (AHI &gt;=15 event/hour, indications for CPAP treatment) renal artery abnormalities eGFR &lt; 60mL/min previous TIA, stroke, heart failure Type 1 diabetes ICD or pacemaker others</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>hypertension, resistant</keyword>
	<keyword>obstructive sleep apnea</keyword>
	<keyword>renal denervation</keyword>
	<keyword>continuous positive airway pressure therapy</keyword>
</DOC>